ArticleHemaSphere2026

Transitioning CAR-T therapy for multiple myeloma to the outpatient setting: First clinical insights with cilta-cel in Germany.

Christof Scheid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.